Sentinel lymph node detection with large human serum albumin colloid particles in breast cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 6, 2003, Pages 874-878

  Mirzaeil, S ^a   Rodrigues, M ^a   Hoffmann, B ^a   Knoll, P ^a   Riegler Keil, M ^a   Kreuzer, W ^a   Salzer, H ^a   Kohn H ^a   Polyak A ^b   Janoki G A ^b  

^a WILHELMINEN HOSPITAL   (Austria)

^b National Research Institute for Radiobiology and Radiohygiene Budapest   (Hungary)

Author keywords

Breast cancer; Human serum albumin colloid; Lymphoscintigraphy; Particle size; Sentinel lymph node

Indexed keywords

ALBUMIN TC 99M COLLOID; DYE; RADIOPHARMACEUTICAL AGENT; SENTI SCINT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARTICLE SIZE; PROGNOSIS; PROSPECTIVE STUDY; RELIABILITY; SCINTISCANNING; SENTINEL LYMPH NODE; SURGICAL ANATOMY; TISSUE DISTRIBUTION;

EID: 10744221395     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1147-8     Document Type: Article

References (18)

1. Veronesi U, Rilke F, Luini A, et al. Distribution of axillary node metastases by level of invasion: an analysis of 539 cases. Cancer 1987; 59:682-687.
2. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
3. Morton D, Wen D, Cochran A. Management of early stage melanoma by intraoperative lymphatic mapping and selective lympadenectomy: an alternative to routine elective lymphadenectomy or "watch and wait". Surg Oncol Clin North Ann 1992; 1:247-259.
4. Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399.
5. Reintgen DS, Cruse CW, Bermann C, et al. An orderly progression of melanoma nodal metastases. Ann Surg 1994; 220:759.
6. Rutgers EJTh, Muller SH, Hoefnagel CA. The use of intraoperative probes in surgical oncology. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, 2nd edn. London: Churchill Livingstone; 1998:1025-1036.
7. Tanis PJ, van Sandick JW, Nieweg OE, et al. The hidden sentinel node in breast cancer. Eur J Nucl Med 2002; 29:305-311.
8. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000; 30:25-32.
9. Wilher AJ, Mijnhout S, Franssen EJF. Radiopharmaceuticals in sentinel lymph-node detection. An overview. Eur J Nucl Med 1999; 26 Suppl:36-42.
10. Krag D, Weaver D, Ashikagat T. et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339:941-946.
11. Tafra L. Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001; 233:51-59.
12. Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med 1999; 26:57-67.
13. Van Lancker M, Goor C, Sacre C, et al. Patterns of axillary lymph node metastasis in breast cancer. Am J Clin Oncol 1995; 18:267-272.
14. Paganelli G, De Cicco C, Cremonesi M, et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1998; 42:49-53.
15. Valdés Olmos R, Hoefnagel C, Nieweg O. Optimized mammary lymphoscintigraphy using larger colloid particles [reply]. J Nucl Med 2001; 42:826.
16. Alazraki NA, Styblo T. Grant S, et al. Breast cancer sentinel lymph node lymphoscintigraphy: comparison of subdermal and peritumoral injections. J Nucl Med 1999; 40:59.
17. De Cicco C, Cremonesi M, Luini A, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 39:2080-2084.
18. Paganelli G. Sentinel node biopsy: the role of nuclear medicine in conservative surgery of breast cancer. Eur J Nucl Med 1998; 25:99-100.